DKC1 and neoplasm: Interestingly, when patients were stratified by the expression of SENP3, DKC1 lost its role as an indicator for poor outcomes among patients with lower expression of SENP3 (Fig. 8H, I), implicating that SUMOylated DKC1 might exert a more robust pro-tumor effect.